68Ga-Based radiopharmaceuticals: production and application relationship
2015 (English)In: Molecules, ISSN 1420-3049, E-ISSN 1420-3049, Vol. 20, no 7, 12913-12943 p.Article, review/survey (Refereed) Published
The contribution of 68Ga to the promotion and expansion of clinical research and routine positron emission tomography (PET) for earlier better diagnostics and individualized medicine is considerable. The potential applications of 68Ga-comprising imaging agents include targeted, pre-targeted and non-targeted imaging. This review discusses the key aspects of the production of 68Ga and 68Ga-based radiopharmaceuticals in the light of the impact of regulatory requirements and endpoint pre-clinical and clinical applications.
Place, publisher, year, edition, pages
2015. Vol. 20, no 7, 12913-12943 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-267055DOI: 10.3390/molecules200712913ISI: 000368695400076PubMedID: 26193247OAI: oai:DiVA.org:uu-267055DiVA: diva2:871950